EKF Diagnostics Announces Total Voting Rights Update

EKF Diagnostics Holdings ( (GB:EKF) ) just unveiled an announcement.

EKF Diagnostics Holdings plc announced that its total issued share capital consists of 449,093,790 ordinary shares, with 7,330,636 shares held in treasury, resulting in 441,763,154 shares carrying voting rights. This information is crucial for shareholders to determine their interest in the company’s share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings has a solid financial foundation with strong profitability and low leverage, which is a major strength. The positive earnings call further supports the stock’s potential with strategic growth initiatives. However, technical indicators show bearish momentum, and the valuation is moderate, which tempers the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings plc is an AIM-listed global diagnostics company specializing in point-of-care analyzers, particularly in hematology and diabetes, as well as life sciences services. The company is involved in the specialist manufacture of enzymes and custom products for diagnostic, food, and industrial applications. Headquartered in Penarth, near Cardiff, EKF operates five manufacturing sites across the US and Germany, distributing its products to over 120 countries worldwide.

Average Trading Volume: 553,059

Technical Sentiment Signal: Strong Sell

Current Market Cap: £115.7M

See more data about EKF stock on TipRanks’ Stock Analysis page.